Iain D. Dukes - Oct 6, 2021 Form 4 Insider Report for Theseus Pharmaceuticals, Inc. (THRX)

Role
Director, Chairman
Signature
/s/ Bradford Dahms - Attorney-in-Fact
Stock symbol
THRX
Transactions as of
Oct 6, 2021
Transactions value $
$0
Form type
4
Date filed
10/8/2021, 07:00 PM
Previous filing
Jul 1, 2021
Next filing
Dec 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRX Stock Option (right to buy) Award $0 +22.7K $0.00 22.7K Oct 6, 2021 Common Stock 22.7K $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/36th of the options vesting monthly after October 6, 2021, subject to the Reporting Person's continuous service with the issuer.